U69593

Term ID

CHEBI:73357

Synonyms

(5alpha,7alpha,8beta)-(-)-N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-benzeneacetamide
N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide
N-methyl-N-((5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-benzeneacetamide
U 69,593
U 69593
U-69593

Definition

A monocarboxylic acid amide obtained by formal condensation between the carboxy group of phenylacetic acid and the secodary amino group of (5R,7S,8S)-N-methyl-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-amine.

References

Ontology

ChEBI ( EBI )

Resources

CTD

Relationships

is a type of: monocarboxylic acid amide N-alkylpyrrolidine organic heterobicyclic compound oxaspiro compound

monocarboxylic acid amide N-alkylpyrrolidine organic heterobicyclic compound oxaspiro compound Show first 5 Terms
has_role: anti-inflammatory agent diuretic kappa-opioid receptor agonist

anti-inflammatory agent diuretic kappa-opioid receptor agonist Show first 5 Terms

Phenotype

Phenotype resulting from U69593

Phenotype where environments contain U69593

Phenotype modified by environments containing U69593

Human Disease Model